Efficacy of blood-patch pleurodesis for secondary spontaneous pneumothorax in interstitial lung disease

Internal Medicine

Volumn 50, Issue 11, 2011, Pages 1157-1162

  Aihara, Kensaku ^a   Handa, Tomohiro ^a,b   Nagai, Sonoko ^c   Tanizawa, Kiminobu ^a   Watanabe, Kizuku ^a   Harada, Yuka ^a   Chihara, Yuichi ^a   Hitomi, Takefumi ^a   Oga, Toru ^a   Tsuboi, Tomomasa ^a   Chin, Kazuo ^a   Mishima, Michiaki ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c Central Clinic in Kyoto   (Japan)

Author keywords

Interstitial lung disease; Pleurodesis; Pneumomediastinum; Pneumothorax; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PATCH; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMORBIDITY; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTERSTITIAL LUNG DISEASE; MALE; PATIENT SAFETY; PLEURODESIS; PNEUMOMEDIASTINUM; PROGNOSIS; RETROSPECTIVE STUDY; SPONTANEOUS PNEUMOTHORAX; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PLEURODESIS; PNEUMOTHORAX; PROGNOSIS; RECURRENCE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79958075437     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.4645     Document Type: Article

References (32)

1. McLoud TC, Carrington CB, Gaensler EA. Diffuse infiltrative lung disease: a new scheme for description. Radiology 149: 353-363, 1983.
2. Picado C, Gomez de Almeida R, Xaubet A, et al. Spontaneous pneumothorax in cryptogenic fibrosing alveolitis. Respiration 48: 77-80, 1985.
3. Franquet T, Gimenez A, Torrubia S, Sabate JM, Rodriguez-Arias JM. Spontaneous pneumothorax and pneumomediastinum in IPF. Eur Radiol 10: 108-113, 2000.
4. Soskel NT, Sharma OP. Pleural involvement in sarcoidosis. Curr Opin Pulm Med 6: 455-468, 2000.
5. Mendez JL, Nadrous HF, Vassallo R, Decker PA, Ryu JH. Pneu-mothorax in pulmonary Langerhans cell histiocytosis. Chest 125: 1028-1032, 2004.
6. Almoosa KF, McCormack FX, Sahn SA. Pleural disease in lym-phangioleiomyomatosis. Clin Chest Med 27: 355-368, 2006.
7. Eastridge CE, Hamman JL. Pneumothorax complicated by chronic steroid treatment. Am J Surg 126: 784-787, 1973.
8. MacDuff A, Arnold A, Harvey J; BTS Pleural Disease Guideline Group. Management of spontaneous pneumothorax: British Thoracic Society Pleural Disease Guideline 2010. Thorax 65 (Suppl 2): ii18-ii31, 2010.
9. Goldszer RC, Bennett J, VanCampen J, Rudnitzky J. Intrapleural tetracycline for spontaneous pneumothorax. JAMA 241: 724-725, 1979.
10. Macoviak JA, Stephenson LW, Ochs R, Edmunds LH. Tetracy-cline pleurodesis during active pulmonary-pleural air leak for prevention of recurrent pneumothorax. Chest 81: 78-81, 1982.
11. Almassi GH, Haasler GB. Chemical pleurodesis in the presence of persistent air leak. Ann Thorac Surg 47: 786-787, 1989.
12. Almind M, Lange P, Viskum K. Spontaneous pneumothorax: comparison of simple drainage, talc pleurodesis, and tetracycline pleurodesis. Thorax 44: 627-630, 1989.
13. Kennedy L, Sahn SA. Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest 106: 1215-1222, 1994.
14. Brant A, Eaton T. Serious complications with talc slurry pleurodesis. Respirology 6: 181-185, 2001.
15. Okuma T, Matsuoka T, Hamamoto S, Nakamura K, Inoue Y. Percutaneous computed tomography-guided radiofrequency ablation of lung tumors complicated with idiopathic interstitial pneumonia. Ann Thorac Surg 87: 948-950, 2009.
16. Robinson CL. Autologous blood for pleurodesis in recurrent and chronic spontaneous pneumothorax. Can J Surg 30: 428-429, 1987.
17. Dumire R, Crabbe MM, Mappin FG, Fontenelle LJ. Autologous "blood patch" pleurodesis for persistent pulmonary air leak. Chest 101: 64-66, 1992.
18. Mallen JK, Landis JN, Frankel KM. Autologous "blood patch" pleurodesis for persistent pulmonary air leak. Chest 103: 326-327, 1993.
19. Cagirici U, Sahin B, Cakan A, Kayabas H, Buduneli T. Autolo-gous blood patch pleurodesis in spontaneous pneumothorax with persistent air leak. Scand Cardiovasc J 32: 75-78, 1998.
20. Ando M, Yamamoto M, Kitagawa C, et al. Autologous blood-patch pleurodesis for secondary spontaneous pneumothorax with persistent air leak. Respir Med 93: 432-434, 1999.
21. Rinaldi S, Felton T, Bentley A. Blood pleurodesis for the medical management of pneumothorax. Thorax 64: 258-260, 2009.
22. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 165: 277-304, 2002.
23. Travis WD, Hunninghake G, King TE, et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med 177: 1338-1347, 2008.
24. Williams P, Laing R. Tension pneumothorax complicating autolo-gous "blood patch" pleurodesis. Thorax 60: 1066-1067, 2005.
25. Hyzy R, Huang S, Myers J, Flaherty K, Martinez F. Acute exacerbation of idiopathic pulmonary fibrosis. Chest 132: 1652-1658, 2007.
26. Agarwal R, Jindal SK. Acute exacerbation of idiopathic pulmonary fibrosis: a systematic review. Eur J Intern Med 19: 227-235, 2008.
27. Bjoraker JA, Ryu JH, Edwin MK, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 157: 199-203, 1998.
28. Matsuoka S, Kurihara Y, Yagihashi K, Okamoto K, Niimi H, Nakajima Y. Thin-section CT assessment of spontaneous pneu-momediastinum in interstitial lung disease: correlation with serial changes in lung parenchymal abnormalities. Respir Med 100: 11-19, 2006.
29. Fujiwara T. Pneumomediastinum in pulmonary fibrosis. Detection by computed tomography. Chest 104: 44-46, 1993.
30. Nagai S, Kitaichi M, Izumi T. Classification and recent advances in idiopathic interstitial pneumonia. Current Opinion in Pulmonary Medicine 4: 256-260, 1998.
31. Nagai S, Handa T, Kim D. Pharmacotherapy in patients with idi-opathic pulmonary fibrosis. Expert Opin Pharmacother 9: 1909-1925, 2008.
32. Miyamoto K, Aida A, Nishimura M, Aiba M, Kira S, Kawakami Y. Gender effect on prognosis of patients receiving long-term home oxygen therapy. The Respiratory Failure Research Group in Japan. Am J Respir Crit Care Med 152: 972-976, 1995.